JCPenney (JCP) Taps Legendary 'New Coke' Mastermind in Turnaround Effort

Go back to JCPenney (JCP) Taps Legendary 'New Coke' Mastermind in Turnaround Effort

JCPenney (JCP) CEO Johnson Continues Testimony in Martha Stewart (MSO) Case (M)

March 4, 2013 10:49 AM EST

J.C. Penney Co., Inc. (NYSE: JCP) CEO Ron Johnson is testifying again in the Macy's (NYSE: M)/Martha Stewart Omnimedia (NYSE: MSO) case this morning.

Johnson said, in part, he wouldn't have entered a contract "if Macy's deal was breached."

Shares of JCPenney are down 1.6 percent Monday.... More

J.C. Penney (JCP) Situation Has Gone from Bad to Worse, Thinks Analyst

March 1, 2013 3:24 PM EST

According to its most recent Q4 report, the situation at J.C. Penny (NYSE: JCP) has gone from bad to worse. This is illustrated by a dramatic fall in comps, which declined 32 percent. According to analysts at Gilford Securities, there is no reason for investors to become bullish at this time, and the risk of failure is increasing.
... More

J.C. Penney (JCP) IDRs Downgraded to B- at Fitch

February 28, 2013 5:06 PM EST

Fitch Ratings has downgraded the Issuer Default Ratings (IDRs) on J.C. Penney Co., Inc. (NYSE: JCP) and J.C. Penney Corporation, Inc. to 'B-' from 'B'. The Rating Outlook is Negative.

The rating downgrades reflect Fitch's concerns that there is a lack of visibility in terms of the company's ability to stabilize its business in 2013 and beyond after a... More

Pershing Square's Ackman Caught Between Rock and Hard Place (HLF) (JCP)

February 28, 2013 9:03 AM EST

Pershing Square's Bill Ackman is having a terrible, horrible, no good, very bad day.

Exhibit A) Herbalife (NYSE: HLF) closed 3.6 percent higher on Wednesday and is now largely back to the same spot where it dropped in December on word that Ackman was short about 20 million shares. Last week, Herbalife even... More

J.C. Penney (JCP) Slammed on Weak Q4

February 27, 2013 4:41 PM EST

J.C. Penney Co., Inc. (NYSE: JCP) is trading down 7 percent following weak results and comps. The company reported Q4 EPS of ($1.95), $1.77 worse than the analyst estimate of ($0.18). Estimates may not compare. Revenue for the quarter came in at $3.88 billion versus the consensus estimate... More